P Jessmon, T Boulanger, W Zhou… - Expert review of …, 2017 - Taylor & Francis
Introduction: While ovarian cancer (OC) is relatively rare, it remains one of the most fatal cancers. Lack of robust screening methods for eOC lead to detection of most cases at …
N Sargazi, R Daroudi, K Zendehdel… - Value in Health …, 2022 - Elsevier
Abstract Background Gynecological cancers (GCs) are an important cause of morbidity and mortality among women worldwide. The incidence of cancer is increasing in Iran, and …
P Simic, I Pljesa, L Nejkovic, D Jerotic, V Coric, J Stulic… - Medicina, 2022 - mdpi.com
Chemotherapy resistance of ovarian cancer, regarded as the most lethal malignant gynecological disease, can be explained by several mechanisms, including increased …
L Delgado-Ortega, A González-Domínguez… - The European Journal of …, 2019 - Springer
Objective To assess the economic burden of epithelial ovarian cancer (EOC) in incident patients and the burden by disease stage in Spain. Methods We developed a Markov model …
IB Poonawalla, DR Lairson, W Chan, LB Piller, XL Du - Value in Health, 2015 - Elsevier
Background The use of neoadjuvant chemotherapy (NAC) in the treatment of advanced ovarian cancer has increased in recent years. There is uncertainty about NAC's …
KE Broekman, M Jalving, H Van Tinteren… - Cancer treatment …, 2018 - Elsevier
Background The magnitude of clinical benefit scale (MCBS) was introduced by the European Society of Medical Oncology (ESMO) to quantify the clinical benefit of therapeutic …
A Dagovic, K Matter Walstra, SF Gutzwiller… - Eur J Oncol, 2014 - researchgate.net
Aims: Assessment of direct medical costs of cancer diagnosis and treatment for newly diagnosed cancer patients; analysis of patterns of medical service utilization; description of …
A Dagovic, A Zugic, MB Jakovljevic - Experimental and Applied …, 2015 - sciendo.com
Healthcare financing in Serbia has faced many challenges over the past few decades. One of the most severe challenges is a global macroeconomic recession whose far-reaching …